Article Listing - STOCK MARKET COMMENTARY: NEW YORK

NEG LIST TALKS CONTINUE IN SPAIN

27 April 1992

Talks are continuing between the Spanish Health Ministry and the Spanish pharmaceutical industry association, Farmaindustria, on the selective financing of...

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

US biotechnology company Bio-Technology General Corp has received approval to market Eskatrope, its recombinant version of human growth hormone which...

UPJOHN'S GLYNASE APPROVED IN USA

27 April 1992

Upjohn has received marketing approval from the US Food and Drug Administration for an improved formulation of its leading antidiabetic...

SOTALOL BEST, SAYS ARRHYTHMIA STUDY

27 April 1992

Results of an arm of the ESVEM (electrophysiologic study versus electrocardiographic monitoring) study have indicated that the beta blocker and...

IVAX CORP ACQUIRES WAVERLEY PHARMA

27 April 1992

US-based Ivax Corporation has acquired the British company Waverley Pharmaceutical for around L 22 million ($38.5 million) in stock. The...

BELMAC EUROPE LAUNCHES EPO PRODS

27 April 1992

Belmac Europe has launched three oral powder formulations of erythromycin, under the trade name Biolid, onto the French market. The...

"STRINGS" WITH US ACCELERATED APPRO

27 April 1992

The accelerated approval proposal which the US Food and Drug Administration published this month changes the set of principles which...

Japan FTC To Reduce Antitrust Exemptions

27 April 1992

Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...

ISRAEL'S TEVA BUYING HUNGARIAN FIRM

27 April 1992

According to press reports confirmed by senior executives at Israeli drugmaker Teva, the company is at an advanced stage of...

INST FARMA SERONO POSTS LOWER PROFITS

27 April 1992

Instituto Farmacologico Serono, which is listed on the Rome bourse, ended 1991 with 6.7 million lire ($5.4 million) profit, down...

Showing 94351-94360 of 95579 articles